Drug intelligence / Profile preview

CHYR TONG DAN SOLUTION

Development stage
Unknown
Lead developer
Min Tong Chemical Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

CHYR TONG DAN SOLUTION is an over-the-counter (OTC) multi-symptom cold and flu medication manufactured by Min Tong Chemical Pharmaceutical in Taiwan. Despite the manufacturer's association with traditional Chinese medicine, this product is a conventional small molecule pharmaceutical combination. It contains acetaminophen (paracetamol) for pain and fever relief, chlorpheniramine maleate as an antihistamine to reduce runny nose and sneezing, DL-methylephedrine hydrochloride as a decongestant and bronchodilator, and caffeine anhydrous to counteract drowsiness and enhance analgesic effects. It is indicated for the symptomatic relief of the common cold and influenza, including fever, headache, muscle aches, nasal congestion, and cough.

Brand names
CHYR TONG DAN SOLUTION治痛單液
Other names
Chyr Tong Dan Solution
02

Targets

ADORA2A (Adenosine A₂A Receptor)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)ADORA1 (Adenosine receptor A1 subtype)ADRB1 (β1)COX

Beyond the preview

Go deeper on CHYR TONG DAN SOLUTION.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHYR TONG DAN SOLUTION.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call